Medical Condition News

RSS

Minorities with MS may face risk of developing depressive symptoms

Multiple sclerosis can cause significant physical impairment, including fatigue, pain, muscle spasms, tremors and dizziness. For many with MS, the disease wreaks havoc with emotional well-being, too, and according to a new study, minorities might especially be at risk for developing depressive symptoms.

23 Dec 2010

Novel method to analyze fatigue through speech

What can scientists learn from watching a group of people sitting around, chatting, playing movies, reading, and happily making new friends? Quite a lot, says University of Melbourne, Australia acoustician Adam Vogel, who carefully observed this sort of group in a fatigue management study he and his colleagues describe this month in The Journal of the Acoustical Society of America.

22 Dec 2010

People with high RBC folate levels more likely to have two tumor-suppressing genes

People with higher levels of folate in their red blood cells were more likely to have two tumor-suppressing genes shut down by methylation, a chemical off switch for genes, researchers report in the December issue of Cancer Prevention Research.

22 Dec 2010

Researchers identify class of drugs that can promote RBC formation in anemic patients

By determining how corticosteroids act to promote red blood cell progenitor formation, Whitehead Institute researchers have identified a class of drugs that may be beneficial in anemias, including those resulting from trauma, sepsis, malaria, kidney dialysis, and chemotherapy.

22 Dec 2010

Tekmira begins patient dosing in TKM-PLK1 phase 1 trail for cancer

Tekmira Pharmaceuticals Corporation, a leading developer of RNA interference therapeutics, announced today it has initiated patient dosing in a Phase 1 human clinical trial for its lead oncology product, TKM-PLK1. TKM-PLK1 targets polo-like kinase 1, or PLK1, a cell cycle protein involved in tumor cell proliferation and a validated oncology target.

22 Dec 2010

Study finds specially designed probiotic can prevent obesity

Specially designed probiotics can modulate the physiology of host fat cells say scientists writing in Microbiology. The findings could lead to specialised probiotics that have a role in the prevention or treatment of conditions such as obesity.

22 Dec 2010

Researchers perform cord blood cell transplantation to treat child with ischemic brain injury

In three monthly injections, researchers transplanted neurally-committed, autologous cord blood derived cells tagged with iron oxide nanoparticles into the lateral cerebral ventricle of a 16-month old child with severe global hypoxic ischemic brain injury.

22 Dec 2010

Antares Pharma submits NDA for Anturol Gel in patients with overactive bladder

Antares Pharma, today announced the filing of a New Drug Application with the U.S. Food and Drug Administration for Anturol Gel in patients with overactive bladder.

22 Dec 2010

Children with autism may have problem with visual skills: Study

A new study suggests that children with autism may lack certain visual skills needed to be independent in adulthood. Researchers at the University of Bristol in the United Kingdom said they might find it difficult to spot something.

22 Dec 2010

Autism discrimination case at Perth Methodist college

A Perth girl’s school admitted to discriminating against an autistic pupil who was denied a trained aide. This made her lose nine months of schooling. Methodist Ladies College in Perth’s wealthy western suburbs in a first of its kind case in Australia was forced to apologise to parents Andrew and Mandy Mason after they took the school to the Federal Court and secured a settlement in their favour.

22 Dec 2010

Snowblowers can cause severe hand injuries during winter

It's the peak season for snowstorms, and snowblowers are working overtime. But Loyola University Health System hand surgeon Dr. Randy Bindra cautions that snowblowers can cause severe hand injuries, including loss of fingers that can require one or more surgeries and months of rehabilitation.

22 Dec 2010

Millennia compiles data on 100 wounds treated with Cytomedix AutoloGel System

Cytomedix, Inc. a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today announced that its Japanese partner, Millennia Holdings, Inc. ("Millennia"), has compiled data on 100 wounds treated with the Company's AutoloGel™ System, and will use this initial data to support its regulatory and reimbursement filings in Japan. The full data set is expected to be released through presentations at scientific and medical meetings and through publication in a peer-reviewed journal.

22 Dec 2010

Arena, Eisai complete lorcaserin NDA end-of-review meeting with FDA

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today the completion of an end-of-review meeting with the US Food and Drug Administration (FDA) for the lorcaserin New Drug Application (NDA).

22 Dec 2010

Delcath completes NDA submission for chemosaturation system

Delcath Systems, Inc. today announced that the Company has submitted the remaining modules of its 505(b)(2) New Drug Application (NDA) for its proprietary chemosaturation system to the U.S. Food & Drug Administration (FDA). The Company had previously submitted Module 4, consisting of literature based non-clinical data, to the FDA in late April 2010. The Company is seeking an indication for the percutaneous intra-arterial administration of melphalan hydrochloride for use in the treatment of patients with metastatic melanoma in the liver.

22 Dec 2010

NIH Clinical Center opens doors to Damon Runyon Clinical Investigators

A new pilot partnership between the National Institutes of Health Clinical Center, the National Cancer Institute's Center for Cancer Research, and the Damon Runyon Cancer Research Foundation will offer some of the capabilities and expertise of America's research hospital to an external group of clinical investigators in cancer research. The special talent and resources of the NIH will allow Damon Runyon-funded investigators to undertake studies and collaborations that will advance understanding of the prevention, diagnosis, and treatment of cancer.

22 Dec 2010

NAHN and Partnership at Drugfree.org join to address teen drug and alcohol use in the Hispanic community

The Partnership at Drugfree.org today announced a new strategic partner to help support the organization's outreach to address teen drug and alcohol use within the Latino and Spanish-speaking community and equip Hispanic parents with tools from prevention to treatment of drug and alcohol abuse. The National Association of Hispanic Nurses (NAHN) has joined with the national nonprofit to provide bilingual resources to Spanish-speaking parents and caregivers and help promote the group's online tools and resources across various NAHN communication channels.

22 Dec 2010

Excessive carbohydrates, rather than fat, may be the source of America's dietary woes

A growing number of top nutritional scientists are pointing to excessive carbohydrates, rather than fat, as the source of America's dietary woes. As reported in the Los Angeles Times on December 20, some researchers are saying that cutting carbohydrates is the key to reversing obesity, heart disease, Type 2 diabetes and hypertension.

22 Dec 2010

FDA issues CRL to Cumberland's Acetadote sNDA for non-acetaminophen acute liver failure

Cumberland Pharmaceuticals Inc. announced today that it has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) regarding its supplemental new drug application (sNDA) for Acetadote® (acetylcysteine) Injection to treat patients with non-acetaminophen induced acute liver failure.

22 Dec 2010

BioCryst commences BCX4208/allopurinol combination Phase 2b study in gout patients

BioCryst Pharmaceuticals, Inc. announced the initiation of a Phase 2b study of BCX4208 as add-on therapy in gout patients who have not responded to allopurinol therapy alone.

22 Dec 2010

Virtual technology to train social workers to help address mental health needs of veterans

Real-life application of revolutionary virtual technology to train and teach in the classroom will be the focus of the University of Southern California's display and presentations at the Consumers Electronics Show (CES) Jan. 6-10 at the Las Vegas Convention Center.

22 Dec 2010

Medical Condition News

Minorities with MS may face risk of developing depressive symptoms

Novel method to analyze fatigue through speech

People with high RBC folate levels more likely to have two tumor-suppressing genes

Researchers identify class of drugs that can promote RBC formation in anemic patients

Tekmira begins patient dosing in TKM-PLK1 phase 1 trail for cancer

Study finds specially designed probiotic can prevent obesity

Researchers perform cord blood cell transplantation to treat child with ischemic brain injury

Antares Pharma submits NDA for Anturol Gel in patients with overactive bladder

Children with autism may have problem with visual skills: Study

Autism discrimination case at Perth Methodist college

Snowblowers can cause severe hand injuries during winter

Millennia compiles data on 100 wounds treated with Cytomedix AutoloGel System

Arena, Eisai complete lorcaserin NDA end-of-review meeting with FDA

Delcath completes NDA submission for chemosaturation system

NIH Clinical Center opens doors to Damon Runyon Clinical Investigators

NAHN and Partnership at Drugfree.org join to address teen drug and alcohol use in the Hispanic community

Excessive carbohydrates, rather than fat, may be the source of America's dietary woes

FDA issues CRL to Cumberland's Acetadote sNDA for non-acetaminophen acute liver failure

BioCryst commences BCX4208/allopurinol combination Phase 2b study in gout patients

Virtual technology to train social workers to help address mental health needs of veterans

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News